|
1
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Lung Cancer and Personalized medicine. Ahmad A
and Gadgeel S: Springer; Cham: pp. 1–19. 2016, View Article : Google Scholar
|
|
3
|
Yang Z, He J, Gao P, Niu Y, Zhang J, Wang
L, Liu M, Wei X, Liu C, Zhang C, et al: miR-769-5p suppressed cell
proliferation, migration and invasion by targeting TGFBR1 in
non-small cell lung carcinoma. Oncotarget. 8:113558–113570. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu XL, Gong Y and Zhao DP: Elevated PHD2
expression might serve as a valuable biomarker of poor prognosis in
lung adenocarcinoma, but no lung squamous cell carcinoma. Eur Rev
Med Pharmacol Sci. 22:8731–8739. 2018.PubMed/NCBI
|
|
5
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Manupati K, Debnath S, Goswami K, Bhoj PS,
Chandak HS, Bahekar SP and Das A: Glutathione S-transferase omega 1
inhibition activates JNK-mediated apoptotic response in breast
cancer stem cells. FEBS J. 286:2167–2192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Whitbread AK, Masoumi A, Tetlow N, Schmuck
E, Coggan M and Board PG: Characterization of the omega class of
glutathione transferases. Methods Enzymol. 401:78–99. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chirila DN, Chirila MD, Micu BV, et al:
The risk of gastric cancer in patients with glutathione
s-transferases (GSTS) gene polymorphisms. Hum Vet Med. 10:104–110.
2018.
|
|
10
|
Ada TG, Ada AO, Kunak SC, Alpar S, Gulhan
M and Iscan M: Association between glutathione S-transferase omega
1 A140D polymorphism in the Turkish population and susceptibility
to non-small cell lung cancer. Arh Hig Rada Toksikol. 64:61–67.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu YT, Wang J, Yin R, Qiu MT and Xu L,
Wang J and Xu L: Genetic polymorphisms in Glutathione S-transferase
Omega (GSTO) and cancer risk: A meta-analysis of 20 studies. Sci
Rep. 4:65782014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karacaoğlan V, Ada AO, Bilgen S, Çetinkaya
GT, Soydaş E, Kunak CS, Alpar SM, Gülhan M and Işcan M:
Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and
clinical outcome in advanced nonsmall cell lung cancer patients.
Turk J Med Sci. 47:554–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bulus H, Oguztuzun S, Guler Simsek G,
Kilic M, Oguz Ada A, Göl S, Kaya Kocdogan A, Kaygın P, Bozer B and
Iscan M: Expression of CYP and GST in human normal and colon tumor
tissues. Biotech Histochem. 94:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chuang JJ, Dai YC, Lin YL, Chen YY, Lin
WH, Chan HL and Liu YW: Downregulation of glutathione S-transferase
M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse
bladder carcinogenesis. Toxicol Appl Pharmacol. 279:322–330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang LK, Yue HL, Peng XJ and Zhang SJ:
GSTO1 regards as a meritorious regulator in cutaneous malignant
melanoma cells. Mol Cell Probes. 48:1014492019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Radic T, Coric V, Bukumiric Z,
Pljesa-Ercegovac M, Djukic T, Avramovic N, Matic M, Mihailovic S,
Dragicevic D, Dzamic Z, et al: GSTO1*CC Genotype (rs4925) Predicts
Shorter Survival in Clear Cell Renal Cell Carcinoma Male Patients.
Cancers (Basel). 11:20382019. View Article : Google Scholar
|
|
17
|
Piaggi S, Raggi C, Corti A, Pitzalis E,
Mascherpa MC, Saviozzi M, Pompella A and Casini AF: Glutathione
transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in
cell resistance to cisplatin toxicity. Carcinogenesis. 31:804–811.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding Y, Lu Y, Xie X, Sheng B and Wang Z:
Silencing TRIM37 inhibits the proliferation and migration of
non-small cell lung cancer cells. RSC Advances. 8:36852–36857.
2018. View Article : Google Scholar
|
|
20
|
Besse B, Charrier M, Lapierre V, Dansin E,
Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F,
Laplanche A, et al: Dendritic cell-derived exosomes as maintenance
immunotherapy after first line chemotherapy in NSCLC.
OncoImmunology. 5:e10710082015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Zhao Y, Cao R, Li L, Cai G, Li J, Qi
X, Chen S and Zhang Z: Activity-based protein profiling reveals
GSTO1 as the covalent target of piperlongumine and a promising
target for combination therapy for cancer. Chem Commun (Camb).
55:4407–4410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang SN, Fu J, Shankar S and Srivastava
RK: EGCG enhances the therapeutic potential of gemcitabine and
CP690550 by inhibiting STAT3 signaling pathway in human pancreatic
cancer. PLoS One. 7:e310672012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang T, Ma L, Wu P, Li W, Li T, Gu R, Dan
X, Li Z, Fan X and Xiao Z: Gallic acid has anticancer activity and
enhances the anticancer effects of cisplatin in non small cell lung
cancer A549 cells via the JAK/STAT3 signaling pathway. Oncol Rep.
41:1779–1788. 2019.PubMed/NCBI
|
|
24
|
Wen W, Liang W, Wu J, Kowolik CM, Buettner
R, Scuto A, Hsieh MY, Hong H, Brown CE, Forman SJ, et al: Targeting
JAK1/STAT3 signaling suppresses tumor progression and metastasis in
a peritoneal model of human ovarian cancer. Mol Cancer Ther.
13:3037–3048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou F, Cheng L, Qiu LX, Wang MY, Li J,
Sun MH, Yang YJ, Wang JC, Jin L, Wang YN, et al: Associations of
potentially functional variants in IL-6, JAKs and STAT3 with
gastric cancer risk in an eastern Chinese population. Oncotarget.
7:28112–28123. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
